Better question hylander, has the information even BEEN GIVEN to this point? Would be nice to get a conf call and Joe tell the shareholders where they stand on that. However we get the same answer every time "We would have to pay an add'l $50K to be able to use their name in our press releases about the valuation." I can remember the $300M breast cancer valuation 10 years ago, yup that long. Joe said they could not release the name of the appraisal firm, but it was a big one. Just like he can never release the name of the Tier 1 investment bank they had lined up to fund the uplisting. It all starts at the TOP!
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.